IT-enabled Healthcare Market to soar at 11.8% CAGR till 2020 thanks to Increasing Government Initiatives

IT-enabled healthcare offers viable means of overcoming shortfalls in the existing healthcare delivery system across the world. The key benefits of IT-enablement of healthcare delivery systems include the ability to reach a larger consumer base at minimal cost with efficiency. Companies operating in IT-enabled healthcare market offer numerous efficient solutions to healthcare organizations and practitioners to improve the quality of healthcare services. Moreover, healthcare IT solutions have also enabled individuals to gain access to quality healthcare services remotely without inconvenience of visiting a healthcare facility. It helps to meet challenges such as a poor doctor-to-patient ratio and ensures that essential health services are made available in the remotest of locations. IT-enabled healthcare solutions are utilized for various applications such as general healthcare and fitness, medication information, remote monitoring, collaboration and consultancy, healthcare management, and access to health data and records. The global IT-enabled healthcare market was valued at USD 96.87 billion in 2013 and is expected to grow at a CAGR of 11.8% during the forecast period 2014 – 2020.

Read Full Press Release : http://www.transparencymarketresearch.com/pressrelease/it-enabled-healthcare-market.htm

Numerous government policies across the world have generated strong demand for IT enablement of national and district level healthcare facilities. Given the increasing focus of governments across the globe on developing their respective country’s healthcare infrastructure, public/private healthcare infrastructure is rapidly growing. Countries such as India, China, Brazil, Argentina, Chile, Algeria, and Singapore among others are increasingly spending on public sector health programs through various private and government-sponsored models in an effort to reach out to the masses. Moreover, inefficiencies of the traditional paper-based systems such as incompleteness, redundancies and high costs lead to unnecessary healthcare expenditures. IT-enabled healthcare offers a viable replacement of traditional systems to reduce healthcare costs and increase efficiency and quality of healthcare services. The use of electronic medical records (EMR) and other healthcare information systems ensure continuity of healthcare services regardless of their geographical location. Other benefits offered by healthcare IT solutions such as convenience through remote monitoring, home diagnosis and other mHealth solutions are further driving the growth of IT-enabled healthcare market.

Healthcare IT solutions are used by various healthcare facilities including public/private healthcare institutions, physicians, healthcare workers and individuals. In 2013, public/private healthcare institutions held the largest market share in the overall IT-enabled healthcare market in terms of revenue. The individuals segment is expected to witness the fastest growth during the forecast period from 2014 to 2020 due to the rising awareness and demand for healthier lifestyle. In recent years, the global IT-enabled healthcare market has witnessed huge demand owing to government initiatives and technological advancements. Developed markets such as North America and Europe are comparatively mature markets for healthcare IT solutions as they were the early adopters of eHealth solutions. North America constituted the largest market share in the global IT-enabled healthcare market in 2013. Despite its late penetration in the Asia Pacific region, the IT-enabled healthcare market is expected to witness tremendous growth during the forecast period from 2014 to 2020 due to government initiatives in the region. The RoW region is also expected to offer immense growth opportunities in IT-enabled healthcare market on account of the ongoing healthcare reforms in Middle East and Africa region.

Request Sample pages of premium Research Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3918

McKesson Corporation, Cerner Corporation, and Koninklijke Philips N.V. were identified to be the top three players in the IT-enabled healthcare market in 2013. Other key players in the IT-enabled healthcare market include GE Healthcare, Siemens AG, IMS Health Holdings Inc., Allscripts Healthcare Solutions Inc., eHealth Technologies, E*HealthLine.Com Inc., AirStrip Technologies LP, Aerotel Medical Systems Ltd., Johnson & Johnson Healthcare Systems Inc., AT&T Inc. and Apple Inc.

New Trends of Global Bioinformatics Market with Worldwide Industry Analysis to 2020

The global bioinformatics market is expected to grow at a CAGR of 15.5% between 2014 and 2020. The market was worth US$10.04 bn in 2013 and is projected to reach US$30.87 bn by the end of 2020. The drug development segment is anticipated to lead all application segments. North America is expected to maintain its dominance in the global bioinformatics market with a revenue worth US$11,927.9 mn by 2020. Asia Pacific is expected to witness the highest growth with a CAGR of 18.7% throughout the forecast period.

The prevalence of high entry barriers is estimated to increase the rivalry between the numerous existing companies in the global bioinformatics market, making it highly fragmented. The existing companies are focusing on the implementation of acquisition strategies and collaborations in order to enhance their product portfolio and expand their market reach.

Read Full Report: http://www.transparencymarketresearch.com/bioinformatics-market.html

The implementation of expansion strategies to enhance market share will increase the intensity of competitive rivalry on the global level for the existing market players, reports Transparency Market Research in a new study. To maintain their position in the global bioinformatics market, the large number of market players operating in the global bioinformatics market are investing in research and development projects. They are also looking forward towards technological advances for increasing application in biosciences and integrated information technology. The top three market players in the global bioinformatics are Affymetrix Inc., Accelrys Inc., and CLC bio A/S. They together comprise approximately 34.6% of the overall global bioinformatics market in 2014.

Growing Need for Technological Advancements to Augment Demand for Bioinformatics Techniques

The expansion of biotechnology applications in fields of forensic research and disease diagnosis is drawing the attention of various healthcare organizations and professionals. According to the TMR report, biotechnology with technological and process advancements tends to create high-wage job opportunities in developing and developed countries due to which governments are focusing on the growth of the biotechnology industry.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=656

For instance, The Biotechnology Industry Organization of the United States of America promotes collaborations between industry participants, academic organizations, and state governments of the country in order to develop bioscience groups. In this regard, the state governments are also increasing the implementation of strategies and programs to create job opportunities in the field of bioscience.

Many companies have implemented reimbursement policies funded by the governments to train employees in order to fulfill the requirement of skilled employees working in the field of bioinformatics services. Thus, the initiatives taken by governments to support research and development projects and creation of jobs in the biotechnology sector are anticipated to boost the global demand for bioinformatics services.

Lack of Skilled Workforce Could Hinder Supply Side of Bioinformatics Services

For better and accurate results, it is imperative that the bioinformatics techniques are operated by skilled personnel. The need for heavy investment in installation and tools upgradation training tends to impede the growth of the industry. Due to this, there is a lack of skilled manpower in the bioinformatics sector who can adapt to sophisticated and high-end biotechnology process and techniques. The scarcity of skilled workers is hindering the growth process of large clinical laboratories as they struggle to automate their processes. On the other hand, the small and medium laboratories have amplified their efforts to abridge and boost their operations with the available resources. Research and development activities also demand highly skilled personnel, but the lack of it is obstructing the growth process making it difficult for organizations and market players to benefit from their research investments.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=656

However, the expansion in web-based services for research and development is likely to cut down the cost of R&D processes. The web-based bioinformatics segment is projected to witness substantial growth in the upcoming years in the global bioinformatics market.

Body Fat Measurement Market: North America accounts for the largest regional share due to a large pool of obese population

Body fat analyzers are also known as impedance meters is a tool for accurate assessment of body fat and this identify risk associated with health due to high or low amounts of body fat. Moreover these devices also help assess effectiveness of exercise and nutrition intake and age related ages.Body fat measurement is considered as a common fitness test at gymnasium, health clubs. The body fat measuring device when applied to the skin leads to a passage of weak current between the outer two electrodes. As this high frequency current passes through the skin, the muscles and the subcutaneous fat, some amount of energy is lost due to the tissue resistance. This change in the energy is then measured with the help of two inner electrodes. The body fat measurement devices can be designed to measure the flow at different depths. The body fat percentage varies according to age and gender in an individual. According to the World Health Organization (WHO), over 1.9 billion adults, were reported as overweight worldwide in 2014 and is linked to more deaths as compared to underweight population.

The global body fat measurement market can be segmented based onanalysis method and geography. The different body fat analysis methods include hydrostatic weighing or underwater weighing, bioelectric impedance analysis, skin fold analysis, near-infrared interactance, anthropometric method and BOD POD. Different techniques used to analyze the body fat include dual energy X-ray absorptiometry, magnetic resonance imaging, computerized tomography and air displacement plethysmography. Ultrasound technique can also be used for accurate assessment of body fat and is less expensive than other laboratory methods. The major driver for the market growth is due to the ballooning burden of obese population responsible for rise in rate of disease and disability across the globe.

Hydrostatic weighing is considered as a gold standard by the American College of Sports Medicine (ACSM) due to its high accuracy. BOD POD too works similar to that of hydrostatic weighing, however its high cost restricts its use by many health clubs. Currently, bioelectric impedance analysis is the most popular method for body fat measurement and works on the principle of flow of low-intensity electric current through the body and resistance measurement. The speed of the passage of current determines the percentage of fat and muscle quality in the person. In skin fold analysis, total body fat can be estimated by measuring the fat under the skin. However, this method is not used for measurement of visceral fat. Near-infrared interactance involves placing of a special probe against a body area which emits infrared light that passes through muscle and fat.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5318

In terms of geography, the global body fat measurement market can be segmented into four major regions: North America, Europe, Asia Pacific, Latin America, the Middle East and Rest of the World. North America accounts for the largest regional share due to a large pool of obese population, as well as technologically advances healthcare infrastructure. The region is followed by Europe due to an obesity crisis as per the WHOEmerging economies in Asia Pacific, and Rest of the World hold immense potential for the body fast measurement devices owing to their increasing population, and patient affordability and are expected to boost the growth of the market in these regions.

Some of the key players in the global body fat measurement market include AccuFitness LLC, COSMED Srl, Diagnostic Medical Systems Group, GE Healthcare, Hologic, Inc., Omron Healthcare, and Tanita Corporation.

Health Insurance Market: Business Challenges, Emerging Technologies & Competitive Landscape

Health Insurance Market: Overview

The improving GDPs of several nations across the globe has favored the growth of the global health insurance market in recent years. Health insurance companies have been benefitting from the rising per capita incomes, the emergence of the middle class, and growing number of people with a relatively high income.

The research report by Transparency Market Research has also studied using a SWOT analysis and a Porter’s five forces. The research report includes an explanation of the various factors determining the trajectory of the global health insurance market in the coming few years. Analysts have also factored in opinions of various market experts and leaders to give the readers a fair understanding of the overall market. Additionally, the document includes recommendations for the new entrants and existing players to improve their businesses with the wealth of valuable knowledge about the market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5312

Health Insurance Market: Trends and Opportunities

The efforts invested by several companies to make their product offerings as transparent as possible has fared well over the past few years. This move has made it easier for buyers to compare and understand the terms of insurance and the products being sold to them. Additionally, the integration of solutions through data analytics, cloud computing, and other modeling techniques is also projected to encourage the growth of the global market in the near future.

Despite the positive outlook of the global health insurance market, it faces some tough challenges such as intense competition and tough profit margins. The undulating economic conditions have also led a considerable about of uncertainty in the global market.

Health Insurance Market: Region-wise Outlook

The U.S. is the leading health insurance market in the global market due to its unmatched healthcare system in the world. The growth of the market is predominantly being aided by the strong presence of leading players such as Anthem Inc., Aetna Inc., UnitedHealth Group Inc., Humana Inc., and Cigna Corp. These players occupy a share of about 80% in the private and public sector of insurance in the U.S. The companies are exploring opportunities of digitizing access to insurance schemes and communication about the same with their consumers to reach out to a wider audience. Options such as providing distributors and consumers with self-service features are also likely to open up a plethora of opportunities for the global market. Furthermore, marketing the products in an easily comprehensible manner is also expected to be the strategy of leading players in the coming years. The only threat for the new entrants is the high level of competition in the U.S. health insurance market.

Asia Pacific is expected to a lucrative market as the region has shown a remarkable progress in its GDP. Furthermore, the improving disposable incomes and the enhancement of health security standards are also expected to boost this market in the region in the near future. The growing middle class and an increasing number of high net worth individuals in Asia Pacific are also expected to give the health insurance market the much-needed impetus.

Key Players Mentioned in the Report

Some of the leading players operating in the global health insurance market are Cigna Corporation, AIA Insurance Group, UnitedHealth Group Inc.,Allianz SE, Zurich Insurance Group Ltd., Express Scripts Holding Company, AXA, Aviva plc, Aetna, Inc., Apollo Munich Health Insurance, and International Medical Group.

Personal Emergency Response Systems Market Segment Forecasts up to 2023, Research Reports- TransparencyMarketResearch

A personal emergency response system is an electronic device that allows individual to seek a secure help during an emergency. This is system is connected with other devices such as cell phone or alarm and are programmed to signal a response center upon activation of ‘help’ or a ‘push’ button. This help button is a radiofrequency trigger device that is mostly worn around the wrist or neck. The person at the receiving end of the PERS can even interact with the individual in order to decide which action should be taken. It has been observed that there is an increasing trend towards usage of technologies that allow people to gain easy access to healthcare without any undue effort of staying in the hospital. Therefore, it is expected that the personal emergency response system market will be among the most lucrative component in the home healthcare market.

A basic model of PERS involves the equipment and a facility of call service. The equipment includes a receiver console through which call can be made to the emergency response centre of the PERS center staff of the service provider. The personal emergency response systems and its components those are involved in the remote access and monitoring have now become an indispensible part in the development of the telehealth services. These systems can be expected to be completely integrated with the consumer products such as wristwatch, cell phone, etc. in the near future. Such comprehensive solution will enable easier and independent life for seniors through management of diseases, social interaction and engagement. The major concerning factor that limits the natural growth of the global personal emergency response systems market include the out-of-pocket payments required for covering the cost of equipping the device of availing the service.

The U.S. Census Bureau has estimated that the present senior population in the U.S. is likely to increase from 34 million and reach 74 million by 2025. During the same time, the world population of seniors is set to jump from 550 million to 1.2 billion in 2025. Many people among this population are expected to demand for the home healthcare due to its cost effectiveness over hospitals. The desire to age-in-place has propelled the development of innovative personal emergency response systems. A survey conducted by the AARP International revealed that 90 percent of the baby boomer population wished to leave in their home as they grow older. Patients using personal emergency response system have reported to have increased control over their life, partially reduced dependency on others and more important is the peace of mind. All these favorable factors continue to augment the growth of global personal emergency response system.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6883

The competitive landscape of the global personal emergency response systems market is pretty stable right now with limited players entering into the market. However, the increasing market attractiveness is expected to drive more players into the market and intensify the competition in the near future. These products are distributed both through the retail channel as well as the institutional channel which involves direct or indirect contract with hospitals and large group purchase organizations (GPO). These systems are distributed into the market as a direct purchase option or the service of product is offered on a monthly rental payment for the device.

Some of the key players in the global personal emergency response systems market include Philips Lifeline, Tunstall Healthcare, Life Alert Emergency Response, Inc., ADT LLC, and Numera, Inc.

Geriatric Population Resulting in Increased Number of Diagnostic Check-Ups Boosting Medical Image Analysis Software Market

A new market research report by Transparency Market Research, titled “Medical Image Analysis Software Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, is a comprehensive study elaborating on the prime roles of medical image analysis software. Aspects such as the current size of the market and the predicted growth trends in the forecast period from 2015 to 2013 have also been included in this study. In addition, the report also throws light on the chief performing products in the market, along with stating the estimated performance of these products all through the forecast horizon. Furthermore, the top application segments as well as end-use segments have also been presented via this research report in order to provide a detailed study on the market for medical image analysis software.

According to this research report, the advantages associated with the utilization of medical image analysis software such as easy readability, sharing and storing of images, and rising productivity are boosting the market for medical image analysis software. In addition, factors such as the rising geriatric population resulting in increased diagnostic check-ups and the rising convenience owing to image availability on mobile devices are also amongst the chief factors fuelling the market, as per this study. On the other hand, factors such as the issues of data security and the soaring costs of software may have a negative effect on the growth of the market.

On the basis of imaging modality, the report segments the market into magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT) and positron emission tomography (PET), x-ray, computed tomography (CT), microscopy, and ultrasound. In terms of end use, the market for medical image analysis software is segmented into diagnostic centers and general hospitals.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5306

The report, on the basis of geography, segments the market into Europe, Asia Pacific, North America, and Rest of the World (RoW). Amongst these, North America leads the market and is trailed by Europe. This is owing to the swift technological advancements and the increasing demand for n-dimensional and platform-independent image processing and visualization in these two regions. On the other hand, as per the report, Asia Pacific emerged as the most lucrative medical image analysis software market and is poised to grow at a rapid rate in the coming years. This is owing to the rising occurrence of diseases requiring diagnostic tools, enhancement in health care facilities, and increasing government initiatives in this region.

Carestream Health, Toshiba Medical Systems Corporation, Bruker Corporation, and Merge Healthcare, among others, are the major players operating in the market, as per this study.

Healthcare Analytics Market Outlook and Forecast up to 2023

A new research study by Transparency Market Research presents a complete overview of the global market for healthcare analytics. The report, titled “Healthcare Analytics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, is available for sale on TMR’s website.

According to the research report, the increasing pressure to control healthcare expenses is the key driving force behind the growth of this market.

The study analyzes the global healthcare analytics market on four fronts: type, application, end user, and regional spread. On the basis of analytics type, the report classifies this market into descriptive analytics, predictive analytics, and prescriptive analytics. Among these, the descriptive analytics segment is likely to occupy a dominant share of the market over the forecast period.

Based on application, the healthcare analytics market is segmented into predictive analytics, big data analytics, HIPAA, and genomics. Public health systems, accountable care organizations (ACOs), private healthcare providers, monitoring agencies, health insurance firms, clinical research organizations, medical research bodies, and technology vendors are the prime end users of healthcare analytics across the world, states the report.

Regionally, the report divides the global market for healthcare analytics into North America, Asia Pacific, Europe, and the Rest of the World. Among these, North America has acquired the leading position at present. The high number of market players present in the U.S. is the prime factor behind the dominance of the North America healthcare analytics market.

Analysts at TMR expect this regional market to retain its leadership during the forecast period. The U.S. healthcare mandates providing quality care and aimed at controlling the increasing healthcare costs are likely to boost the healthcare analytics market in North America in the near future.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5309

The report further states that the markets for healthcare analytics in Asia Pacific, Europe, and the Rest of the World have also been gaining impetus due to the rising demand for the treatment of diseases in their early stages, better clinical outcomes, and the increasing efficacy of the healthcare procedures in these regions.

The research report also presents a study of the competitive landscape of the global healthcare analytics market, by analyzing the company profiles of major market players. According to it, this market is fragmented and highly competitive. The presence of a large pool of market participants is the key factor behind this.

Truven Health Analytics Inc., Allscripts Health Solution, Cognizant, Oracle Corp., Mede Analytics Inc., Cerner Corp., IBM Corp., Verisk Analytics Inc., MedAssets Inc., Health Catalyst, Inovalon Inc., Mckesson Corp., Optum Inc., and SAS Institute Inc. are some of the key players operating in the worldwide healthcare analytics market, states the market study.

Wireless Health Market: Emerging Technology, Industry survey and Analysis – 2023

The e-health monitoring system with wireless sensor network is used for patient telemonitoring and telemedicine. A 2012 article titled ‘In-home health monitoring to leap six-fold by 2017’ illustrated that Wireless remote monitoring devices will be used by more than 1.8 million people worldwide in the next four years. Of the billions of dollars spent on health care each year, 75% - 80% of it accountsfor patients with chronic illnesses such as diabetes, heart disease, asthma and Alzheimer’s disease. Over a decade, healthcare industry has taken a measured approach pertaining tointegrationof information technology (IT). Recent federal legislation and emerging trends, however, are changing the landscape and driving the need to accelerate the adoption of health IT in healthcare especially in medical devices.

Among wireless health products wearable medical devices is expected to be the fastest growing segment. Information delivered by modern wearable medical devices is easy to interpret and hence popularity is expected to increase rapidly within non-medical personnel. With these devices, peoplecan quickly modify their lifestyle to better improve their physical stature. Devices that measure temperature, heart rate and other parameters can be of paramount importance while determining physical fitness of a person.Over 65% of technologies are wrist held devices shaped like watches and the rest are wearable on other areas of the body such as arms, torso and waist. Along with the aesthetics, several other features for durability of the device are included such as waterproofing and weatherproofing. The latest in developments is telecommunication, wireless connectivity and improved user interface. The advent of smartphones has resulted in multi-fold increase of growth in applications that can now extend to storage and retrieval of history for the individual for long term mapping and improvement of fitness.

Some of the major factors driving this market are the decreasing costs of electronics that has now made these devices available to middle and even low income groups over the world, and increased use of internet globally. According to the World Bank, number of internet users per 100 people increased from 15.8 in 2005 to 38.1 in 2013. The global wireless health market by products encompasses ECG monitors, insulin monitors, neuromonitors such as EEG and EMG devices.There are several devices which have in-build capability to diagnose, detect and send patient records to a centralized servers which can be easily accessed by healthcare providers. Advantages of wireless health devices encompasses patient comfort, accurate detection and analysis, access to stored patient data for a considerable longer period of time i.e. weekly or monthly. Recently Engineers at the University of Illinois at Urbana-Champaign and Northwestern University have demonstrated stick-on patches which can be used on a daily basis to monitor patient’s ECG. Additionally, the patient record can be easily accessed through a cell phone or computer wirelessly.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5663

Geographically the market can be studied for four geographical regions: North America, Europe, Asia Pacific and Rest of the Word. Currently, North America in terms of revenue accounts for the largest share owing to burgeoning population of cardiovascular diseases, diabetic patients. Moreover government initiatives such as the Affordable Care Act and favorable reimbursement scenario also promotes the sales and adoption of innovative wireless health monitoring and diagnostic products. Followed by the U.S., Europe holds the second leading position in the current scenario. Historically, the major EU countries have always been at the forefront of developing innovative healthcare technologies.In November 2013, Belgium-based research center Imec showcased its ideas for wearable sensor technologies for remote healthcare and personal health applications. The company introduced a body patch that integrates an ultra-low power electrocardiogram (ECG) chip and a Bluetooth low-energy radio. The company has also developed a prototype of a patient-friendly wireless EEG headset together with Holst Centre and Panasonic. Asia Pacific and Rest of the World market are among the fastest growing and largely untapped market. High cost of devices and lack of awareness about these devices are among the major restraint to the current adoption of the products in emerging market.

Some of the key players operating in this market encompasses Omron Corporation, GE Healthcare, Koninklijke Philips N.V., Polar Electro, Nihon Kohden, Siemens A.G., Mckesson Corporation,and Cerner Corporation.

Healthcare IT (Provider and Payer) Market Will Reflect Significant Growth Prospects during 2015-2023

A report by Transparency Market Research (TMR) presents a detailed overview of the global healthcare IT market. The report is titled “Healthcare IT (Provider and Payer) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”.

The report analyzes the various elements of the healthcare IT market, the market featuring information technology solutions aimed at the digitization the healthcare industry. The information technology industry has offered a variety of solutions with the help of which many legacy healthcare systems and innumerous processes have become automated and computer controlled. The rising integration of such solutions in the modern-day healthcare industry has led to a significant reduction in response time, errors in data storage and processing, and has led to efficient delivery, management, and storage of the vast amount of data in the healthcare industry.

The increasing awareness regarding numerous benefits offered by IT in healthcare has fuelled demand for healthcare IT solutions in the past few years and healthcare IT represents one of the fastest growing sectors of healthcare industry these days.

The report analyzes all the important elements of the market on a global as well as a regional level. For the purpose of study, the market is segmented on the basis of four criteria: delivery mode, application, component of healthcare IT system, and geography.

On the basis of application, the market is segmented into provider and payer. On the basis of delivery mode, the market is segmented into on-premise, web-premise, and cloud-premise. Component-wise, the healthcare IT market is segmented into services, hardware, and software.

The report states that the rising pressure for reducing healthcare costs, the rising demand for digitized healthcare records for making healthcare services more effective, high return on investment from healthcare IT solutions, rising prevalence of a number of chronic diseases, and flourishing medical tourism in Asian countries are some of the key factors driving the global healthcare IT market.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1246

However, some factors such as the fragmented nature of market, high costs incurred in replacing legacy healthcare systems with digital solutions, and high cost of maintenance of healthcare IT solutions as compared to the manually operated ones are hampering the overall growth of the market to a certain extent. Furthermore, the diverse nature of regulatory scenario in developed and developing countries also adversely impacts the growth of the global healthcare IT market.

The market is highly competitive and features the presence of a large number established and new companies. Some of the key companies in the market are McKesson Corporation, GE Healthcare, NextGen Healthcare Information System LLC, Epic Systems, Cerner Corporation, Siemens Healthcare, Philips, Carestream Health, Inc., Allscripts, Medical Information Technology, Inc., Athenahealth Inc., and Hewlett-Packard.

Global Report on Health Care Social Media Marketing Market

Social media marketing is an upcoming field; the emergence of which has been fueled by the rapid rise of social media in recent years. Over the last decade, social media such as Facebook, Twitter, LinkedIn, and others have gone from being a novelty to an everyday necessity. Due to the ease of sharing information with the masses, social media marketing has caught on in the last few years.

Health care is the latest sector to join the social media marketing bandwagon. The ease of sharing information on social media has led many medical equipment manufacturers and other entities in the health care field to advertise their products and services on social media and interact with the customers about the same.

The increasing number of social media users is responsible for the rising demand from the health care social media marketing market. The high proportion of the global population with access to high-speed internet and the requisite amount of tech literacy has led to high demand for the availability of medical knowledge on the internet, thus spurring the global health care social media marketing market.

However, the market is held back by restraints such as the possibility of fraudulent information being passed as genuine and the concern for privacy. The lack of privacy in social media is a well-debated topic already, lending weight to the reluctance of some users to post sensitive medical information on the internet.

Apart from advertising, social media marketing is also a powerful tool for interacting with potential customers. Customer feedback about upcoming products and procedures can even be directly implemented in health care products, making them more in line with what the customer actually needs and wants.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5807

Regionally, North America emerged as the leading market for health care social media marketing in 2014. The high number of tech-savvy customers and rising usage of and government support for telehealth systems are the main factors driving the North America health care social media marketing market. In the coming years, the Asia Pacific and Rest of the World market for health care social media marketing are expected to emerge as strong contenders in the global scenario, due to the rising availability of high-speed internet and growing social media user base in developing countries such as China, India, Indonesia, South Korea, Brazil, Argentina, and Chile.

Dental Fittings Market Segment Forecast up to 2024

Orthodontics mainly deals with the correction of improper alignment of teeth by braces or apparent loss of teeth by dentures/artificial teeth. Orthodontics was initially chosen for children but now it is used ubiquitously. Technological advancements have reduced the stigma related with this treatment and now many dental fittings such as tongue and teeth colored braces are available commercially. Rising awareness of dental aesthetics and related advantages has resulted in increased acceptance of dental fittings amongst all age groups.

The dental fittings include dentures, archwires, anchorage appliances and ligatures. The braces or the brackets are meant to place the misaligned or crooked teeth in place. Braces are small squares attached to the front of the teeth by an orthodontic bonding agent and connected to each other via connectors or bands. Orthodontic bands are stainless steel, tooth colored material or transparent. Spacers are separating parts that fit between the teeth before the bands. Archwires guide braces with the movement of the teeth. Ligatures are small rubber bands which hold on to the archwires together. Traditionally braces were made up of metals, however, with technological advancements they are now available in ceramics. The braces are also made up of stainless steel, titanium or a mixture of both. The orthodontic archwires are of two types: coated metal and transparent non-metallic. Coated metal archwires are made up of nickel- titanium or of stainless steel and are coated with polytetrafluoroethylene (PTFE), parylene-polymer, and an epoxy-resin. Transparent nonmetallic arches are similar to metal arches which are made from glass spindle and are embedded in polymer matrix. The growing demand for aesthetic archwires has led to many advancements in archwires technology. These wires will continuously be developed on the basis of appearance, durability and flexibility. Non-metallic archwires may take over the future market as they are more preferred over the conventional metallic wires. Dentures are used to replace and support the missing teeth and the surrounding gum tissues. Dentures are of two types: complete ones and the partial ones. The partial ones are plastic partials or the metal partials, on the basis of the material used to attach to the teeth.

The dental fittings market is on an all-time high due to many regulatory reforms in most of the countries like reimbursement coverage, access to advanced technology, increased disposable income and increased rate of awareness about dental fittings treatment. Aspects such as rising awareness about dental fittings, cheaper availability of treatment and increasing health care expenditure may boost the growth of the dental fittings market in Asia Pacific. Attributing to rapid development in healthcare, infrastructure, government reforms and access to advanced dental fittings, China and India are most profitable markets in Asia. Also, easy availability of skilled orthodontists and supporting economy is expected to spur the growth of the dental fittings market in China and India.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14195

Many of the companies are manufacturing dental fittings, and are adopting acquisitions and mergers, extensive R&D as measures to expand their geographic reach and introduction of novel products in to the market. Asia Pacific dental fittings market is expected to rise with context to volume, on basis of low product prices, less market penetration, disposable earning and improving healthcare expenditure. Also the awareness of dental aesthetics systems and dental cosmetic surgery will expectedly drive this market in North America and Europe. The advanced CAD/CAM technology and 3 Dimensional digital imaging may lead to growth in the industry. The CAD technology can support in making digital prostheses much faster. The global dental fittings market is dominated by few key players such as GC Orthodontics, Dentaurum, Henry Schein, Hangzhou Shinye, and Dental Morelli.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Growth of Alimentary Tract and Metabolism Market Shifts to High Gear due to Rising R&D by Healthcare Industries

Alimentary tract, also called as alimentary canal,digestive tract/tube, gastrointestinal tract is a hollow passageway of;mucous membrane and muscles that function in digestion. The alimentary canal consists of the mouth,esophagus stomach, small intestine,large intestine, and anus.Metabolism is a biochemical reaction and physical procedure that encompasses maintenance of various functions, such as breathing, blood circulation, muscles movement, digestion of food and nutrients, waste elimination, body temperature control, and proper functioning of brain and nerves of the organism. Metabolism is a pathway that starts with a series of biochemical reactions with a specific molecule and ends with a product with the help of specific enzyme. It is categorized into two processes, i.e. catabolism and anabolism. Catabolism involves breaking down of molecules into simpler energy yielding forms while anabolism involves synthesis of compounds or elements needed by the cell for proper functions.

The disorders related to alimentary tract and metabolism are of very common occurrence and hold high medical significance along with cardiovascular and infectious diseases. The alimentary tract disorders are associated with the impairment of gastrointestinal functions of the system. Improper functioning of gastrointestinal tract can lead to a variety of disorders including irritable bowel syndrome, gastroesophageal reflux diseases, peptic ulcers, constipation, hemorrhoids, colitis, etc. The major causes of these ailments vary and could include genetic abnormalities, the side effects of certain toxins and drugs, infections, cancer, and others. These disorders not only hamper the natural digestive system of the body but also have significant effects on the body metabolism. Some of the most popular brands available in the market for alimentary tract and metabolism are Nexium, Aciphex, Tysabri, and Humira. Growing prevalence of digestive disorders will enhance the growth of alimentary tract and metabolism market. In addition, growing stress, unhealthy dietary lifestyles and increasing geriatric population drives the growth of this market. Furthermore, increasing research and development activities by key players to develop new drugs will further determine the market growth.

On the basis of products, the alimentary tract and metabolism market can be divided into a variety of products used to manage various alimentary tract conditions that includes stomatological preparations, functional gastrointestinal disorders, antacids, antinauseants, laxatives, antidiarrheals, intestinal antiinflammatory/antiinfective agents, antiobesity preparations, vitamins, mineral supplements, tonics, anabolic agents for systemic use, other alimentary tract and metabolism products. Increasing incidences of lifestyle related disorders is one of the major driver for alimentary tract and metabolism market globally.

Geographically, the alimentary tract and metabolism market can be segmented into North America, Europe, Asia Pacific, the Middle East & Africa and Latin America. In 2015, North America dominated the market due to large pool of patients of gastrointestinal disorders in the region. According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than 60 million Americans suffer from one or the other type of digestive diseases annually. Moreover, the rising incidences of colorectal cancer in the United States also support the market growth. The diet has reduced the intake of various healthy foods that increases the incidence of digestive tract problems. Additionally, new and advanced products launches by key players coupled with growing uptake of these drugs by customers further drive the market growth. Developing nations in Asia Pacific are expected to witness the fastest growth during the forecast period. Growing patient pool, increased public awareness and increasing affordability are the major drivers for the market growth in these geographies.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14129

Key players having presence in the alimentary tract and metabolism market include Abbott Laboratories, AstraZeneca, Eisai Co., Ltd., Eli Lilly and Company, F Hoffmann-La Roche, Johnson & Johnson, Novartis AG, Merck KGaA, Sanofi-Aventis, Takeda Pharmaceutical Company.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Leading Players in Intestinal Anti-infective Market

A substance or an agent that aids the immune system by inhibiting infective micro-organisms by inferring with different mechanisms such as cell wall synthesis or DNA synthesis or by slowing their glow. The infection of intestine is known as intestinal infection. Intestinal infection are bacterial, viral or parasitic infections that cause inflammation of gastrointestinal tract that is gastroenteritis. The intestinal infection shows symptoms that includes vomiting, diarrhea and abdominal pain, to treat the intestinal infection anti-infective agents are used. The anti-infective agents kills or suppress the infection causing organism from invading the host organism, such infections are caused by micro-organisms such as fungi, bacteria or viruses. The infection may result from poor hygiene or consuming contaminated food or water. The infection which are caused by food are also called as food poisoning.

Read Full Report: http://www.transparencymarketresearch.com/intestinal-antiinfective-market.html

Rising prevalence of intestinal infections and resistance to anti-infective agents are the key factors driving the market of intestinal anti-infectives globally. In addition, rising awareness among the people and favorable government initiatives for the treatment of infectious diseases is projected to boost the market growth of intestinal anti-infectives market. The expiration of patent for various drugs increase the generic competition in market. The rising demand for extensive R&D efforts to develop new high potency drugs as resistance has been developed by micro-organisms for the drugs is one of the major factor stimulate the growth of global intestinal anti-infective agents market.

The global market of intestinal anti-infectives is classified on the basis of product type, distribution channel and geography. The product type segment is further divided as anti-fungal, anti-viral and anti-bacterial depending upon infection caused by type of micro-organism. The product class includes chemical nature of drug and there mechanism to kill the microbes. The drugs kill the microbes by interfering with the cell wall of the micro-organisms and interfering with protein synthesis.anti-fungal agents are further segmented as Allylamines, Azoles, Polyene, and Macrolides derivatives, these drugs treat the infection caused by fungus. The anti-bacterial segment is further divided in Aminoglycosides, Carbapenems, Cephalosporin, Macrolides, Penicillins, Quinolones, Sulfonamides, and Tetracyclines. These are antibiotics that kills the bacteria by different mechanism. The anti-viral agents are Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, and Protease Inhibitors. These drugs inhibit the nucleic acid synthesis kill or suppress the infective organisms

Geographically the global market for intestinal anti-infective is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Increasing consumption of fast food in North America and changing lifestyle are some of the prime factors driving the growth of intestinal infections in the region, followed by Europe. Thus, owing to the above mentioned factors North America and Europe dominates the global intestinal anti-infectives market. The emerging economies are also promising to show high growth potential in the global intestinal anti-infectives market. Factors such as rising government initiatives and increasing patient pool in countries such as India due to growing awareness supports the growth in Asia Pacific market.

There are also some common trends that affect the market such as generic competition, price issues, and reimbursement issues. Currently, both antifungal and antibacterial segments have experienced heavy generic competition, limiting growth despite introduction of new products to each market segment. Concerns in the antibacterial segment over resistance have resulted in additional funding for new treatments specifically targeting resistant bacteria. Although there seems to be a solution on the surface, many developers are reluctant to follow this development path. Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb, Gilead Science, GlaxoSmithKline, Johnson & Johnson, Novartis and Pfizer are some of the key players having presence in the global intestinal anti-infectives market.

Download Free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14111

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Hospital Clinical Chemistry and Immunodiagnostics Market - Global Markets & Advanced Technologies

Hospital clinical chemistry refers to the area of clinical pathology related to the analysis of body fluids such as blood, urine, etc. and immunodiagnostics is a diagnostic method based on antigen-antibody reaction. There have been remarkable advances in the field of clinical chemistry and immunodiagnostics, resulting into potential diagnostic platform and technologies such as molecular diagnostics, spectrophotometry, electrophoresis, measurement of enzyme activities, and separation of molecules. Clinical chemistry and immunodiagnostics play a critical role to aid the clinicians in the prevention, diagnosis and treatment of diseases. Diseases generally diagnosed with the help of clinical chemistry include viral and bacterial infection, diabetes, thyroid, kidney failure, heart problems, cystic fibrosis in new born babies and screening for illegal drug use.

Based on types of tests, the hospital clinical chemistry and immunodiagnostics market can be segmented as follows:

• Clinical chemistry
• Routine chemistry: It is generally used for the analysis of blood for various tests such as kidney function tests
• Special chemistry: This branch of clinical chemistry uses advanced methods such as electrophoresis
• Drug monitoring: It measures the therapeutic drug medication level in order to determine the right dosage
• Endocrinology: This clinical chemistry test involves the study and diagnosis of endocrine disorders
• Toxicology: It involves the study of drugs of abuse
• Urinalysis: Urinalysis refers to the analysis of urine sample to diagnose a wide array of diseases
• Immunodiagnostics
• Enzyme-Linked ImmunoSorbent Assay or ELISA: ELISA is a commonly used laboratory test that uses a solid-phase enzyme immunoassay (EIA) to detect antibody in the blood sample
• Radioimmunoassay: It is an in vitro assay technique used for the measurement of hormone levels in the blood. One of the examples of radioimmunoassay is the RAST test (radioallergosorbent test) which is used to detect the presence of causative allergen for a specific allergy.

Based on geography, the hospital clinical chemistry and immunodiagnostics market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America holds a leading position in the market followed by Europe. The prime factors which are responsible for the growth of hospital clinical chemistry and immunodiagnostics market in these regions are increasing prevalence of various diseases among the population, and the growing need for technologically advanced diagnostic tests. Moreover, major breakthrough developments in clinical chemistry and immunodiagnostics have resulted in reduction of immunoassay duration and complexity, thereby spurring the growth of the market. Asia Pacific is one of the lucrative markets for the growth of hospital clinical chemistry and immunodiagnostics market due to various emerging economies. Factors which would contribute towards the growth of the market in Asia Pacific are growing need of the population for rapid and cost-effective immunoassay procedures and novel diagnostic platforms. Cost-savings can be achieved with the aid of clinical chemistry and immunodiagnostics due to highly centralized operations and automated data analysis.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6925

Various advances in diagnostic technologies, automation and huge competition in the hospital clinical chemistry and immunodiagnostics market is paving way for a number of opportunities. A number of top companies operating in the market are Abbott, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Siemens AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Alere and others.

Single-Dose Therapy Market Segment Forecast up to 2024

Single-dose therapy can be defined as single drug, or a combination of two or more active pharmaceutical ingredients (API) to be administered in a single dosage form. The drugs combined in the single dosage form contributes to the synergistic effects claimed by each of the drug. The number of doses of the single dose therapy can be increased or decreased, but the therapy does not involving altering of API proportion in the dosage form. These are administered in the form of a vial, capsules, tablets or patch.

Single-dose therapy market can be segmented based on disease indication, application, distribution channel, and geography. Based on disease indication, the market can be segmented into cancer, HIV/AIDS, sexually transmitted diseases, neurological disorders, psychological disorders, and microbial infections, among others. On the basis of application, single-dose therapy market can be segmented into human health and animal health. Hospitals, ambulatory centers, clinics, and pharmacies form the major distribution channels for the market. Based on geography, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Increasing demand due to the synergistic effects provided by the combined fixed dose API’s administered as a single dose is the major driver for the single-dose therapy market. Further, the simpler treatment regime, convenience of administration, and the cost saving offered by single-dose therapy are also expected to drive the market growth. Additional benefits include the combined pharmacokinetics of the component drugs employed in the single dose, and enhanced medication compliance. However, the dosage of the APIs in the single-dose cannot be modified according to the patient requirements, which might negatively impact the growth of the market. In addition, the adverse side effects caused by the component drugs, the allergic reactions from any of the component drugs in the single dose therapy cannot be avoided, which might have an impact on the patient health, and a negative effect on the market growth. Also, the growing over-the-counter sale of various non-approved fixed dose combinations administered as single dose, would adversely affect the market.

Download Complete Healthcare Analytical Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13718

The increasing incidence of sexually transmitted diseases (STDs), and various forms of cancer in all the geographies would drive the demand for single-dose therapies and contribute to the growth of the market. Geographically, North America is the largest market for single-dose therapy, followed by Europe. The growing geriatric population, and increased focus on research and development of effective single dose therapies has been driving the use of single-dose therapies. In addition, the growing FDA approvals of new single-dose therapies would contribute to the growth of the market. For instance, in November 2015, the U.S. FDA approved Genvoya, a single dosage form of various combination drugs for the treatment of HIV-1 infection. Asia Pacific is expected to record significant growth during the forecast period, attributed to the growing economy in the emerging markets of Asia Pacific, growing awareness among people and the increasing geriatric population.

The leading players in the single-dose therapy market include Allergan plc, AstraZeneca plc, Bayer AG, BioCryst Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Gilead Sciences, Inc., Merck & Co., Novartis AG, Pfizer, Inc., and Sanofi S.A., among other significant global market players.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Polymerase Chain Reaction (PCR) Market - An insight on the important factors and trends influencing the market

PCR techniques have paved the way for innovation in life sciences research and molecular diagnostics through its most potential features such as absolute detection and quantification of genetic materials such as DNA and RNA. Researchers are able to quantify and analyze rare alleles and point mutations using advanced PCR systems such as digital PCR. Currently, the market players are engaged in developing PCR systems with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity. Other major advances associated with the PCR include shorter turnaround times (PCR cycling time), higher productivity and automated workflow; thereby ensuring efficient detection and amplification of genetic materials with accurate results. The market is witnessing significant advances in the design of PCR platforms shifting from conventional standard PCR to real time and digital PCR systems to efficiently detect pathogenic microbes such as mycobacterium tuberculosis bacteria and influenza viruses. For instance, introduction of QX200 Droplet Digital PCR System by Bio-Rad provides a broad menu of molecular diagnostic tests and enhanced workflow to enable overall cost reduction and eliminate the need for multiple systems. The global PCR market is valued at USD 6,065 million in 2013 and is expected to reach USD 9,621.0 million with the CAGR of 6.6% during the forecast period of 2014 to 2020.

Although, the use of PCR has been mostly confined to research institutions, pharmaceutical and biotechnology industries, currently, the market has seen an increasing preference of PCR in the commercial diagnostic laboratories and hospitals due to precise diagnoses of life-threatening diseases such as cancer and Ebola. Multi-chain diagnostic laboratories are currently focusing on expanding their operations in less developed areas by acquiring standalone laboratories with minimal infrastructure. Therefore, a strong demand for compact and portable PCR with high reliability and sensitivity is created. All these features along with high affordability are expected to provide impressive growth opportunities for PCR market.

The PCR market is broadly classified on the basis of product segments, end-users and application areas. Among the product segments, reagents and consumables remain the most widely used segment with the largest share in the net sales across various companies, considering the global sales of USD 4,072.2 million in 2013. Among various end-users of PCR, academics and research organization was accounted for the largest market share of overall market in 2013, followed by clinical diagnostic labs and hospitals segment. However, clinical diagnostics segment is likely to grow at an impressive pace during the forecast period of 2014 to 2020. Among the PCR applications area, the life sciences segment is the largest application area covering more than 48% of the total PCR market followed by clinical diagnostics segment with 33% of the market share. The majority market share by the life sciences segment corresponded to its wider acceptance in the cancer research, which is also amongst the oldest segments of PCR application.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=830

Geographically, North America accounted for the largest share of global PCR market in 2013 followed by Europe. These two regions are expected to retain their position throughout the forecast period 2014 to 2020. This is majorly attributed to the presence of technologically sophisticated diagnostic laboratories along with wider acceptance of novel assay technologies. The North American region was among the first to approve and implement the PCR based assays for diagnosis of infectious diseases such as HIV. The Asia Pacific region on the other hand is expected to represent the highest growth rate during the forecast period. This can be attributed to the growing investment in research and development in the region by the Government and private investors. China for example, is at present the world’s second largest investor in research and development according to the World Bank data.

The overall PCR market is consolidated and characterized by the presence of few established players accounting for more than 50% of the total market share. Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Agilent Technologies and Sigma-Aldrich Corporation Beckman Coulter, Bio-Rad, Becton Dickinson and QIAGEN are some of the key players operating in this market.

Medical Plastics Market Witnesses Rising Demand and Investment from R&D Activities

Transparency Market Research holds a large compilation of research reports on the healthcare industry and the medical devices industry. One of the latest titles under the latter is the “Medical Plastics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018,” which aims to assess the various strengths, weaknesses, opportunities, and restrictions that the market will experience over the given forecast period.

The greatest factor responsible for the growth of the global medical plastics market is the increasing demand for disposable medical devices. A large number of healthcare organizations are insisting on disposable medical devices as they help maintain a better standard of hygiene and prevent the reuse of devices such as syringes and needles. Another driver of the global medical plastics market is the increasing need for better quality plastics that can increase the shelf life of medical devices. Other factors promoting the growth of this market are the increasing trade of medical devices due to relaxing international trade laws and an increase in the overall expenditure on healthcare.

There are also the improvements in the materials themselves that are again pushing the global medical plastics market forward. These include the reduction in weight of the plastics without compromising on durability and the safe use of non-metallic i.e., plastic medical devices around magnetic fields created by medical equipment such as the MRI.

One of the restrictions on the global medical plastics market is the care that needs to be taken in disposing the plastic medical devices. Bodies such as the Healthcare Plastics Recycling Council, or the HPRC are active in this space. The HPRC can provide assistance to medical organizations in managing the safe disposal of medical devices. This is a highly advantageous step for medical bodies towards adhering to the increasingly stringent regulations imposed by governments pertaining to the control of ecological damage caused by unmonitored disposal.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1115

The use of plastics in the healthcare sector spans a wide array of fields, including packaging, in most types of modern medical devices, and especially the disposable medical devices.

From a regional perspective, the U.S. has consistently held the largest share in the global medical plastics market in the recent past. The nation’s dominant position is attributed to its highly advanced healthcare infrastructure, the presence of key global players, and the high medical expenditure coupled with greater awareness of the use of quality medical devices.

The key players in the global medical plastics market include Alcan Packaging, Tekni Plex Corporation, ExxonMobil Corporation, Saint Gobain Performance Plastics, Cyro Industries, Bayer, Du Pont, The DOW Chemical Company, Baxter International, Becton and Dickinson, and BASF SE.

Medical devices outsourcing emerged as cost-effective solution in various disciplines of medicine

The global medical devices outsourcing market is driven by rising demand for quality healthcare services, ongoing developments in the field of medical technology, and parallel operational requirements to cut costs for long term sustainability.The global market, which is seeing a rising trend of services and product outsourcing by leading global players to small and specialized service providers in emerging markets, is broadly categorized into product outsourcing and services outsourcing markets.

The medical devices services market is highly diversified and market leaders are expanding their portfolio to tap the high potential. The global medical devices market can be segmented based on factors such as – Application: Class I medical devices, Class II medical devices, and Class III medical devices, and Services: Product design and development services, Regulatory consulting services, Product testing services, Product implementation services, Product upgrade services, and Product maintenance services. Geographically, the market is segmented into Asia Pacific,Europe, North America, andRest of the World (RoW).

Competition amongst medical device manufacturers and the urge to increase profit margins is driving the demand for medical devices outsourcing. Increased product recalls have also boosted demand for services such as testing services and validation services. Among all the geographic regions,North America holds the largest share of medical devices outsourcing market due to the growing healthcare costs. The high penetration and coverage by medical insurance providers in the region too is further helping to boost the demand for quality healthcare services, forcing industry players to outsource services. The fast developing Asia Pacific market is continuously attracting foreign players to leverage market potential, and as a result, service providers in the region are continuously looking for higher and advanced quality certifications.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=361

Within the medical devices manufacturing industry, orthopedic devices constitute the leading share with cardiology devices quickly catching up as the fastest growing device type being outsourced for manufacturing services. The need for integration of other supportive technologies, such as telecommunications, digital imaging and diagnostics, robotics, and many more is further contributing to the market growth and guiding the entry of players from different industries into the market. By application, Class II devices are the largest market share holder due to moderate associated risks and limited regulatory requirements. However, due to high technical and manufacturing cost containment challenges, product design services form the largest market segment of all other medical device services outsourced. Also, outsourcing is helping companies to focus on other business activities and manage their product life cycles, which again is driving the market growth.